Genetic predisposition to childhood cancer

T Ripperger,B Schlegelberger

doi:10.1007/s00292-018-0542-7

T Ripperger, B Schlegelberger

Open Access

https://doi.org/10.1007/s00292-018-0542-7

Copy DOI

Journal: Pathologe	Publication Date: Nov 5, 2018
Citations: 7	License type: CC BY 4.0

Affiliation: Hochschule Hannover, Hannover Medical School

Abstract

Tackling the topic of genetic predisposition to childhood cancer requires close co-operation between pathologists, pediatric oncologists, and human geneticists. It is not just about the precise diagnosis and the most effective treatment of the cancer, but also to prevent further cancerous diseases for those affected and also their family members. On the basis of examples such as Li-Fraumeni syndrome, constitutional mismatch repair deficiency (CMMRD), medullo- and neuroblastoma, as well as hematological neoplasias, we will discuss the criteria for tumor predisposition genetic syndromes, the relationship between somatic and germline variants, and the immediate clinical consequences. In some cases, the diagnosis of agenetic tumor predisposition syndrome has immediate consequences for the treatment, e. g. to avoid radiotherapy for Li-Fraumeni syndrome, which would otherwise significantly increase the probability of secondary, independent tumors. Predictive diagnostics can be offered to identify the family members who carry the pathogenic variant. Because of their increased tumor risk, they should be integrated into cancer surveillance programs. Evidence-based data show that this significantly improves overall survival.

Highlights

On the basis of examples such as Li-Fraumeni syndrome, constitutional mismatch repair deficiency (CMMRD), medullo- and neuroblastoma, as well as hematological neoplasias, we will discuss the criteria for tumor predisposition genetic syndromes, the relationship between somatic and germline variants, and the immediate clinical consequences
The diagnosis of a genetic tumor predisposition syndrome has immediate consequences for the treatment, e. g. to avoid radiotherapy for Li-Fraumeni syndrome, which would otherwise significantly increase the probability of secondary, independent tumors
Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Fruhwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, Von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Korholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Riess O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, Von Schweinitz D, Simon T, SparberSauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, Von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wossmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP (2017) Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

Summary

Monate

Tab. 3 Beginn der Früherkennungsuntersuchungen für Constitutional-Mismatch-Repair-Defizienz(CMMRD)- und Lynch-Syndrom im Vergleich. (Nach Jarvinen et al [4] und Vasen et al [18]) Tab. 3 Beginn der Früherkennungsuntersuchungen für Constitutional-Mismatch-Repair-Defizienz(CMMRD)- und Lynch-Syndrom im Vergleich. (Nach Jarvinen et al [4] und Vasen et al [18])

35 Jahre 25 Jahrea

Findings

Literatur